Date Filer Title Filing Type Shares Traded Price Total Held
Feb 15, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,000 -- --
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 5,000 -- --
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,210 -- --
Apr 01, 2021
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Sep 03, 2020
Chief Medical Officer
Chief Medical Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Feb 15, 2024
GENERAL COUNSEL
GENERAL COUNSEL Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 402 $1.27 3,525
Mar 06, 2023
General Counsel
General Counsel Form 3 Initial Statement of Beneficial Ownership of Securities -- -- 39,270

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.